PATENT CLAIM ANALYSIS

Application Number: 16023363
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["540", "578000"]

Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Claim (Index 2):
The compound of  claim 1 , wherein L is \u2014CONH\u2014 or \u2014NHCO\u2014.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 94.0
- Lexical Diversity: 1.63265
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15216119', '15159548', '15914016', '11997048', '15501079']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7626919124204306
- 35 USC 102 Novelty (BERT): 0.5517474739603608
- Combined Prediction Score: 0.7415974685744237
- Mean Citation Score: 410.19655
- Max Citation Score: 430.20917
- Similarity Product: 276.5568800023919

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test